BO4 Stock Overview
Borregaard ASA engages in the development, production, and marketing of specialized biomaterials and biochemicals in Norway, rest of Europe, the United States, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
Borregaard ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr16.20 |
| 52 Week High | kr16.92 |
| 52 Week Low | kr12.52 |
| Beta | 0.47 |
| 1 Month Change | 4.38% |
| 3 Month Change | 15.22% |
| 1 Year Change | 10.96% |
| 3 Year Change | -10.79% |
| 5 Year Change | 81.07% |
| Change since IPO | 91.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| BO4 | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 0.4% | -0.3% | 1.7% |
| 1Y | 11.0% | -0.3% | 2.3% |
Return vs Industry: BO4 exceeded the German Chemicals industry which returned 0.2% over the past year.
Return vs Market: BO4 exceeded the German Market which returned 2.2% over the past year.
Price Volatility
| BO4 volatility | |
|---|---|
| BO4 Average Weekly Movement | 3.7% |
| Chemicals Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: BO4 has not had significant price volatility in the past 3 months.
Volatility Over Time: BO4's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 1,127 | Per Sørlie | www.borregaard.com |
Borregaard ASA engages in the development, production, and marketing of specialized biomaterials and biochemicals in Norway, rest of Europe, the United States, Asia, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers for various applications, such as agrochemicals, batteries, industrial binders, and construction; and biovanillin for flavor and fragrance companies, as well as for food and beverage industry.
Borregaard ASA Fundamentals Summary
| BO4 fundamental statistics | |
|---|---|
| Market cap | €1.62b |
| Earnings (TTM) | €71.33m |
| Revenue (TTM) | €617.00m |
22.7x
P/E Ratio2.6x
P/S RatioIs BO4 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BO4 income statement (TTM) | |
|---|---|
| Revenue | kr7.26b |
| Cost of Revenue | kr2.66b |
| Gross Profit | kr4.59b |
| Other Expenses | kr3.76b |
| Earnings | kr839.00m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 17, 2024
| Earnings per share (EPS) | 8.41 |
| Gross Margin | 63.30% |
| Net Profit Margin | 11.56% |
| Debt/Equity Ratio | 48.7% |
How did BO4 perform over the long term?
See historical performance and comparison